Apr 08, 2019 (Market Exclusive via COMTEX) — PDL BioPharma, Inc.
PDLI, +0.79%
Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. BeginningonApril9,2019,PDLBioPharma,Inc.(the“Company”)willmakepresentationsandparticipatein …
PDL BioPharma, Inc. (NASDAQ:PDLI) Files An 8-K Regulation FD Disclosure
PDL BioPharma, Inc. (NASDAQ:PDLI) Files An 8-K Regulation FD Disclosure
{$excerpt:n}